摘要
Tuberculosis(TB)is a formidable global health problem and ranks above HIV as the leading cause of death world wide.In2017,a total number of 10.0 million cases of TB were reported, which resulted in1.3 million TB deaths. Resistance to standard anti-TB
基金
supported by Guangzhou Municipal Industry and Research Collaborative Innovation Program [201508020248,201604020019]
Guangzhou Municipal Clinical Medical Center Program [155700012]
partially by the Key Project Grant [SKLRD2016ZJ003] from the State Key Lab of Respiratory Disease,Guangzhou Institute of Respiratory Diseases
Science and Technology Innovation Leader of Guangdong Province [2016TX03R095,to TZ]
by the UCAS Fellowship Program(to H.M.A.H)
by the CAS-TWAS President’s Fellowship(to G.C)
